Awadhesh Kumar Chaudhary, Senior Economic Advisor, Department of Pharmaceuticals chaired the conference. During the conference, very detailed and enriching presentations were made by the experts.
The Court observed that if policy to make cancer medicine affordable is not promulgated, majority of the country's population will be vulnerable to the disease given the unaffordability
The Central government has accorded approval to eight companies under the production linked incentive (PLI) scheme to promote domestic manufacturing of medical devices.
The PLI scheme in pharma aims to enhance India's manufacturing capabilities by increasing investment and production, and boosting exports in 10 sectors.